4.7 Letter

Assessment of salivary antibody response to BNT162b2 mRNA COVID-19 vaccination

Related references

Note: Only part of the references are listed.
Article Microbiology

COVID-19 Serology at Population Scale: SARS-CoV-2-Specific Antibody Responses in Saliva

Pranay R. Randad et al.

Summary: This study found that salivary antibodies could be a noninvasive alternative for monitoring SARS-CoV-2 infection and seropositivity at a population scale. The results showed a high correlation between salivary and serum antibodies, and high sensitivity and specificity of salivary antibodies for detecting COVID-19 infection.

JOURNAL OF CLINICAL MICROBIOLOGY (2021)

Editorial Material Medical Laboratory Technology

Kinetics and biological characteristics of humoral response developing after SARS-CoV-2 infection: implications for vaccination

Giuseppe Lippi et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)

Article Medical Laboratory Technology

Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series

Elisa Danese et al.

Summary: The BNT162b2 mRNA vaccine elicits a strong humoral immune response, particularly involving anti-SARS-CoV-2 IgG and IgA, which is further amplified by the second vaccine dose.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)

Article Medical Laboratory Technology

Antibody response to first and second dose of BNT162b2 in a cohort of characterized healthcare workers

Andrea Padoan et al.

Summary: The study found significant differences in antibody levels at day 12 after receiving the BNT162b2 vaccine between infection-naive individuals and those with previous natural infection, but no differences were observed thereafter. There were no statistically significant differences between males and females, while individuals over 60 years of age had lower antibody levels at day 12 but not at day 28. The influence of sex and age on vaccine responses warrants further investigation, with age showing particular significance.

CLINICA CHIMICA ACTA (2021)

Article Multidisciplinary Sciences

Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

Mark J. Mulligan et al.

NATURE (2020)

Article Medical Laboratory Technology

SARS-CoV-2 identification and IgA antibodies in saliva: One sample two tests approach for diagnosis

Ada Aita et al.

CLINICA CHIMICA ACTA (2020)

Article Dentistry, Oral Surgery & Medicine

Salivary IgA and IgE levels in healthy subjects: relation to age and gender

Abdollah Jafarzadeh et al.

Brazilian Oral Research (2010)